Telemedicine to Support Living Kidney Donor Candidates

Purpose

The goal of this feasibility clinical trial is to learn if telemedicine can be used to provide education and evaluation and counseling for people who are considering living kidney donation. The study will also learn how participants improve decision-making about living kidney donation. The main questions to answer are: - Is telemedicine a practical way to facilitate donor education and evaluation and counseling? - Does telemedicine shared decision making help improve donor candidate decision and engagement during the donor evaluation process? Researchers will compare standard care with a telemedicine care coordination approach. Participants will: - Receive either standard care or telemedicine video visits to support shared decision making.

Conditions

  • Healthy
  • Living Kidney Donation

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 18 years of age or older - Reside in the State of California - Registered living kidney donor candidate at UC Irvine Medical Center

Exclusion Criteria

  • Individuals with a contraindication to living kidney donation (for example, heart disease, cancer)

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Health Services Research
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
Standard Care Group (Control)
Participants in the standard care group will receive a recorded video education session and one in-person donor evaluation and counseling session with a nephrologist.
  • Behavioral: Standard Care (in control arm)
    This Standard Care involves a recorded video education and in-person visit.
    Other names:
    • Control
Experimental
Telemedicine Group (Intervention)
Participants in the telemedicine group will receive two live telemedicine video sessions: one education session with a transplant provider and one donor evaluation and counseling session with a nephrologist.
  • Behavioral: Telemedicine Shared Decision-Making
    This intervention involves two live telemedicine video visits.
    Other names:
    • Experimental

Recruiting Locations

University of California Irvine Medical Center
Orange, California 92868
Contact:
Steven Vasquez
714-456-7431
stevenv4@hs.uci.edu

More Details

NCT ID
NCT07206069
Status
Recruiting
Sponsor
University of California, Irvine

Study Contact

Fawaz Al Ammary, MD PhD
657-223-4966
fawaz.alammary@uci.edu

Detailed Description

Living kidney donation provides a vital treatment option for patients with kidney failure, but many willing individuals face challenges in completing the donor evaluation and committing to donation. Donor education and counseling are essential for informed decision-making, yet these steps are often limited to in-person visits at transplant centers. This can create logistical challenges, delays, and variations in access to the living donor evaluation process. Telemedicine offers an opportunity to deliver a shared decision making approach to donor education and evaluation and counseling remotely, but its feasibility, acceptability, and impact have not been well studied. This pilot feasibility clinical trial is designed to test whether a telemedicine care coordination can support donor decision-making and engagement during the evaluation process for living kidney donation. Participants will be randomly assigned to one of two groups: - Standard Care Group (Control): A recorded video education session and an in-person donor evaluation and counseling with a nephrologist. - Telemedicine Group (Intervention): Two live telemedicine video sessions-one for education with a transplant provider and one for donor evaluation and counseling with a nephrologist. The findings from this feasibility trial will provide important information about the practicality and acceptability of telemedicine shared decision-making for living kidney donor candidates. Generated preliminary data will inform larger trials and ultimately guide transplant practice and policy to improve decision-making, efficiency, and access to living kidney donation.